Market research
COO The Cooper Companies, Inc
NASDAQ USD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 11B
- P/E ratio
- 19.91
- Analyst target
- 65.8
- Dividend yield
- Not available
- Beta
- 0.82
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- Not available
- Market cap
- 11B
- P/E ratio
- 19.91
- Analyst target
- 65.8
- Dividend yield
- Not available
- Beta
- 0.82
About
About The Cooper Companies, Inc
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Research context
The Cooper Companies, Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the COO discussion.
5 years, 6 months ago
The Cooper Companies, Inc is currently in a long term uptrend where the price is trading 10.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.8.
The Cooper Companies, Inc's total revenue rose by 5.3% to $680M since the same quarter in the previous year.
Its net income has increased by 2221.7% to $2B since the same quarter in the previous year.
Finally, its free cash flow grew by 51.2% to $92M since the same quarter in the previous year.
Based on the above factors, The Cooper Companies, Inc gets an overall score of 5/5.